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Diabetes 
Part 1. Definition, Diagnosis and Prevention 
Victor Lawrencea BSc, MB BS, MRCP, Consultant Physician, The Arun Baksi Centre for 
Diabetes and Endocrinology, St Mary's Hospital, Isle of Wight PO30 5TG, UK 
 
Introduction 
Western countries are experiencing an explosion in the prevalence of type 2 diabetes (T2DM) linked to 
increasing obesity and a steady year on year rise in the incidence of type 1 diabetes (T1DM) in children. 
However, for reasons that are not currently understood, the situation in Sub-Saharan Africa is less clear.  Many 
factors contribute to this.  Problems reported in other African countries include: 
 
 failure of patients to present to health care facilities (either because of rapid death in T1DM or lack of clear 
symptoms in T2DM  sometimes linked to malnutrition); 
 targeting of acute infection rather than less cost effective long term conditions in healthcare prioritisation and 
 problems with the reliable supply, affordability and storage of insulin, other medications and the means to 
monitor treatment (e.g. finger prick blood testing).  
  
Some population studies in Africa have suggested that type 1 diabetes is a rare condition.  Sadly, this is more 
likely to be due to the fact that those affected die undiagnosed within a few weeks and so are rarely counted.  
Some studies have suggested under-diagnosis even amongst patients presenting to hospital with ketoacidosis.   
 
In spite of this, we know that diabetes is a common condition affecting perhaps 2-6% of most populations and 
its under-diagnosis and under-treatment leads to rapid death in T1DM and to unnecessary suffering and 
premature death in T2DM.  This article aims to: 
 increase awareness of the condition;  
 discuss symptoms and diagnostic criteria; 
 consider screening and prevention of diabetes; 
 point the reader in the direction of more detailed open access information (see references below).   
The management of diabetes will be discussed in the next issue of the Bulletin 
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Definition of diabetes 
Diabetes is a disorder of the regulation of blood 
glucose.  The World Health Organisation (WHO) 
defines diabetes on the basis of an oral glucose 
tolerance test  (OGTT) (Table 1).  The American 
Diabetes Association (ADA) defines diabetes and 
impaired fasting glucose on the basis of fasting 
plasma glucose (FPG) only - which may be more 
cost effective as a screening tool (Table 2) - usually 
reserving OGTT to patients with abnormal fasting 
glycaemia. 
 
Type 1 diabetes is characterised by an absolute 
deficiency of insulin and type 2 diabetes by resistance 
to insulin action.  Most commonly (approximately 









rapid (few weeks) weight loss, lethargy, polyuria, 
polydipsia, blurred vision, ketosis (acetone on breath, 
not always detectable) and profound dehydration or 
shock.   
 
Type 2 diabetes usually affects older individuals, 
especially if obese, and has a more insidious onset 
with fatigue, polyuria, polydipsia, weight loss and 
infections (e.g. boils, candida).  If the disease is not 
recognised, it may present at a later stage with 
established diabetic complications including renal 
failure, peripheral neuropathy or diabetic retinopathy 
or cataract.  Some secondary causes of diabetes (that 
is, diabetes being secondary to another illness or 
condition) occur commonly in populations where 
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Glucose concentration, mmol l-1 (mg dl-1) 
Whole blood Whole blood Plasma*  
Venous Capillary Venous 
Diabetes Mellitus:       
Fasting  >=6.1 (>=110) >=6.1 (>=110) >=7.0 (>=126) 
or       
2-h post glucose load >=10.0 (>=180) >=11.1 (>=200) >=11.1 (>=200) 
or both    
Impaired Glucose Tolerance (IGT):       
Fasting (if measured)  <6.1 (<110) <6.1 (<110) <7.0 (<126) 
and    







>=7.8 (>=140) and 
<11.1 (<200) 
Impaired Fasting Glycaemia (IFG):       
Fasting 
>=5.6 (>=100)  
and <6.1 (<110)
>=5.6 (>=100)  
and <6.1 (<110)
>=6.1 (>=110)  
and <7.0 (<126) 
and (if measured)    
2-h post glucose load <6.7 (<120) <7.8 (<140) <7.8 (<140) 
 
Table 2.  Criteria for the diagnosis of diabetes mellitus (ADA)  
1. Symptoms of diabetes plus casual plasma glucose concentration >11.1 mmol/l (200 
mg/dl). Casual is defined as any time of day without regard to time since last meal. The 
classic symptoms of diabetes include polyuria, polydipsia, and unexplained weight loss. 
OR 
2. Fasting plasma glucose (FPG) >7.0 mmol/l (126 mg/dl). Fasting is defined as no caloric 
intake for at least 8 h. 
OR 
3. 2-h post-load glucose 11.1 mmol/l (200 mg/dl) during an OGTT. The test should be 
performed as described by WHO, using a glucose load containing the equivalent of 75 g 
anhydrous glucose dissolved in water. 
In the absence of unequivocal hyperglycemia, these criteria should be confirmed by repeat testing 
on a different day. The third measure (OGTT) is not recommended for routine clinical use. 
Insulin resistance in comparison to insulin 
deficiency 
It is important to recognise that many individuals are 
hard to define as having pure insulin resistance or 
pure insulin deficiency particularly in the secondary 
forms of diabetes (Table 3). Clinical judgement, 
testing of urine ketones and monitoring of the 
response to treatment (e.g. blood glucose levels,  
 
HbA1c, weight and general wellbeing) is required to 
determine whether insulin treatment will be required 
from the outset, later on or not at all.  Many patients 
who are initially treated as type 2 diabetes with oral 
hypoglycaemic agents (OHAs) will later require 
insulin, and some requiring insulin for treatment of 
HHS (see below) will later be adequately managed on 
tablets and diet alone.   
Table 3. Etiological Classification of Diabetes Mellitus (simplified classification based on 
WHO) 
I. Type 1 diabetes (ß-cell destruction, usually leading to absolute insulin deficiency)  
    A. Immune mediated  
    B. Idiopathic  
II. Type 2 diabetes (may range from predominantly insulin resistance with relative insulin 
deficiency to a predominantly secretory defect with insulin resistance)  
III. Other specific types  
    A. Genetic defects of ß-cell function (MODY, mitochondrial disorders, other) 
    B. Genetic defects in insulin action (e.g. Leprechaunism, congenital lipoatrophic 
disorders) 
   C. Diseases of the exocrine pancreas (e.g. pancreatitis, trauma, pancreatectomy, 
neoplasia,  fibrocalculous pancreatopathy) 
    D. Endocrinopathies (e.g. acromegaly, Cushing’s syndrome, thyrotoxicosis) 
    E. Drug- or chemical-induced (e.g.glucocorticoids, thiazides, phenytoin, antiretroviral 
therapy) 
    F. Infections (e.g. Congenital rubella, Cytomegalovirus, HIV/AIDS) 
    G. Uncommon forms of immune-mediated diabetes (e.g. anti insulin receptor 
antibodies) 
    H. Other genetic syndromes sometimes associated with diabetes (e.g. Prader-Willi 
syndrome) 
IV. Gestational diabetes mellitus (GDM) 
Modified from WHO Study Group on Diabetes Mellitus 
http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf 
Diagnosis and screening 
Diagnosis in acute settings 
Many patients will present to a hospital with a 
metabolic emergency: diabetic ketoacidosis (DKA) in 
T1DM or hyperosmolar hyperglycaemic syndrome 
(HHS, previously sometimes called HONK) in 
T2DM.  Secondary forms of diabetes may take either 
form. Patients with long standing type 2 diabetes 
commonly lose the ability to produce insulin over 
time and require insulin treatment in spite of having 
previously been well controlled with dietary 
modification or oral hypoglycaemic agents (OHAs) 
such as sulphonylureas or metformin.  Excellent 
guidance in the treatment of these conditions, and  
 
 
many other aspects of diabetes is provided by the 
ADA with open access online (see references below).   
 
Diabetic ketoacidosis 
The clinical features of DKA include dehydration, 
shock, vomiting, abdominal pain, acidosis (with 
Kussmaul breathing or, in some cases, ketones on 
the breath), and cerebral impairment.  Biochemical 
features of ketoacidosis include hyperglycaemia, 
ketosis (ketonaemia and ketonuria), metabolic 
acidosis and uraemia.  Creatinine concentrations may 
not be accurately measurable in the presence of 
heavy ketonaemia.  Typical blood results in DKA are 
shown in Table 4. 
Table 4.  Typical initial laboratory values in diabetic ketoacidosis 
Plasma [glucose] = 37mmol/L 
Plasma [K+] = 5.3mmol/L:whole body depletion typically 6.0 mmol/kg body weight 
Plasma [Na+] = 131 mmol/L: whole body depletion typically 8.0 mmol/kg body weight 
Plasma [urea] > 15 mmol/L 
Plasma [creatinine]> 150μmol/L (if possible to measure in the presence of heavy ketonaemia) 
Plasma [ketones] >15 mmol/L 
Plasma [Mg2+] <0.70 mmol/L: whole body depletion typically 0.5 mmol/kg body weight 
Plasma [Pi] >1.2 mmol/L: whole body depletion typically 1.0mmol/kg body weight 
Serum amylase 500-1000 IU/L 
Serum osmolality = 323 mmol/kg 
Whole body water depletion 75-100 mL/kg body weight = 7L in typical adult 
Arterial blood gases 
[H+] > 50 nmol/L (pH <7.30) 
PaCO2 = 3.2kPa 
PaO2 > 12kPa 
[HCO3] <18mmol/L 
Anion gap ([Na+] + [K+]) – ([C1-] + [HCO3-]) > 20 mmol/L 
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The key to successful management is, of course, 
recognition of the condition in the first place and 
early institution of fluid, electrolyte and insulin 
replenishment.   
 
Hyperosmolar hyperglycaemic syndrome 
HHS typically presents with very high blood glucose 
levels, severe dehydration, altered mental status and 
electrolyte disturbance in older individuals with type 
2 diabetes.  The condition is commonly associated 
with another intercurrent illness which should be 
suspected and diagnosed (e.g. infection, stroke).  
Ketonuria is light or absent although a type A lactic 
acidosis may be present in more severe cases as a 
result of shock.  Treatment is broadly similar to 
DKA although slower rates of fluid resuscitation and 
insulin infusion are usually appropriate in these 
typically more frail individuals.   
 
In both DKA and HHS it is important to monitor 
serum electrolytes, particularly Na+ and K+ at 
diagnosis and in response to treatment.  Details of 
the treatment are on the ADA website.   
Diagnosis in other settings  
 It is important to recognise that diabetes may 
present in other settings than those outlined above.  
For example, patients with uncontrolled diabetes 
may fail to recover well from surgical procedures 
because of poor wound healing (fibroblast function) 
and susceptibility to infection (neutrophil function).  
Patients at risk should ideally be identified and 
treated to prevent surgical mishap.  Similarly, 
patients with diabetes are more at risk of developing 
a range of other infections. This possibility should be 
remembered particularly where an individual has a 
history of recurrent skin and superficial infections or 
urinary tract infection without other precipitant.   
 
Pregnancy 
Pregnancy is another setting where patients not 
known to have diabetes may present for medical 
care.  It is particularly important to diagnose diabetes 
because of a serious potential threat to the health of 
both mother and child if the condition is not 
recognised and treated appropriately. Diabetes in 
pregnancy may be pre-existing (already diagnosed 
type 1 or type 2 diabetes) or gestational.   
 
Gestational diabetes mellitus (GDM) is defined as 
any form of disturbance of blood glucose regulation 
with onset or first recognition during pregnancy.  
Most often, this will mean a form of diabetes 
developing at around 26-28 weeks gestation and 
remitting at birth. However, sometimes a pregnant 
woman has type 1 or type 2 diabetes which will, of 
course, not remit at delivery.   Clues to this include 
symptoms of diabetes which pre-date the onset of 
pregnancy or a proven gluco-regulatory disturbance 
developing before the 26th week of gestation.   
 
Women with pre-existing diabetes should ideally: 
 plan their pregnancies so that control of blood 
glucose may be optimised prior to conception 
(ideally, FPG 3.5- 5.9 mmol/l and 1 hour post 
prandial capillary blood glucose <7.8 mmol/l) 
and  
 take folic acid 5 mg prior to conception and up 
to the end of the first trimester.   
Poor control of pre-existing diabetes may be 
associated with a 10 fold or higher incidence of 
major congenital anomalies (typically cardiac or 
neural tube defects).  DKA during pregnancy is 
usually fatal to the foetus and frequently to the 
mother.   
 
Suspect gestational diabetes when the risk factors 
listed in Table 5 exist although the precise screening 
programme should reflect the prevalence of the 
disorder and resources available for its diagnosis and 
treatment. 
 
Table 5. Risk factors for GDM 
History of a large baby (e.g. over 4.0 kg) 
Family history of diabetes in a first degree relative 
Obesity 
Unexplained previous late foetal loss 
Older mother (e.g. over 30) 
Previous gestational diabetes 
 
Prevention 
Type 1 diabetes is not thought to be preventable at 
the current time.  Immunosuppressant therapy has 
been tried in the past with some success but the 
dangers of such treatment generally outweigh the 
benefits.  Many cases of type 2 diabetes are however 
preventable with good diet, maintenance of normal 
weight and healthy amounts of exercise.  Some 
studies have shown an additional effect of 
metformin in addition to these measures although 
this is not a substitute for a healthy lifestyle. People 
at risk from diabetes will usually have a family 
history of the condition, be overweight/obese or 
both.  For example, the risk of type 2 diabetes for a 
woman with BMI >35 [kg.m-2] is approximately 93 
times that of a lean woman.  Centrally distributed 
adiposity carries an independent additional risk.   
 
However, not all obese people have diabetes and 
genetic factors (most easily assessed by family 
history) are thought to play a significant part.  
Women with a history of gestational diabetes carry a 
50% lifetime risk of diabetes.  Where resources for 
screening are available, the groups likely to have the 
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highest undiagnosed prevalence of diabetes are those 
with obesity and women with a history of gestational 
diabetes 
References and further reading 
The following freely accessible on-line resources 
provide a wealth of further information and links to 
other relevant sites:   
American Diabetes Association (ADA) Clinical
Practice Guidelines http://www.diabetes.org/ for-
health-professionals-and-scientists/cpr.jsp 
ADA Guidelines on Diabetic Emergencies
http://care.diabetesjournals.org/cgi/content/ful
l/27/suppl_1/s94
National Diabetes Information Clearing House
http://diabetes.niddk.nih.gov/
See also items on page 17. 
